<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05794594</url>
  </required_header>
  <id_info>
    <org_study_id>CHChongqingMU-2</org_study_id>
    <nct_id>NCT05794594</nct_id>
  </id_info>
  <brief_title>3D Printed Personalized Extendable Prosthesis</brief_title>
  <official_title>3D Printed Personalized Extendable Prosthesis Replacement for Limb Preservation in Children With Osteosarcoma: a Preliminary Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yuxi Su</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital of Chongqing Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this type of observational study is to investigate the preliminary effect of 3D&#xD;
      printed personalized extendable prosthesis replacement on limb salvage in children with&#xD;
      osteosarcoma. The main question it aims to answer is:&#xD;
&#xD;
      Is 3D printed personalized extendable prosthesis replacement has a good outcome in limb&#xD;
      salvage pediatric osteosarcomaï¼Ÿ&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Osteosarcoma is one of the most common primary malignant bone tumors in children and&#xD;
      adolescents. In this study, the investigators try to investigate the preliminary effect of 3D&#xD;
      printed personalized extendable prosthesis replacement on limb salvage in children with&#xD;
      osteosarcoma.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2015</start_date>
  <completion_date type="Actual">March 1, 2023</completion_date>
  <primary_completion_date type="Actual">January 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence</measure>
    <time_frame>7years</time_frame>
    <description>Osteosarcoma recurrence rate</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">25</enrollment>
  <condition>Osteosarcoma in Children</condition>
  <arm_group>
    <arm_group_label>3D printed</arm_group_label>
    <description>3D printed personalized extendable prosthesis replacement for limb preservation in children with osteosarcoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>amputation</arm_group_label>
    <description>patients had undergone amputation of the limbs</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>3D printed personalized extendable prosthesis</intervention_name>
    <description>3D printed personalized extendable prosthesis replacement for limb preservation in children</description>
    <arm_group_label>3D printed</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        children with osteosarcoma undergoing prosthesis replacement or limb amputation were&#xD;
        admitted to our hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  tumors of the extremities, with moderate soft-tissue invasion&#xD;
&#xD;
          -  the neurovascular bundle is not invaded, and the tumor can be excised totally&#xD;
&#xD;
          -  no metastatic lesions or metastases can be cured&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  recurrent tumors&#xD;
&#xD;
          -  poorly differentiated tumors&#xD;
&#xD;
          -  poor soft-tissue conditions&#xD;
&#xD;
          -  neurovascular invasion around tumors&#xD;
&#xD;
          -  ineffective chemotherapy with metastasis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuxi Su</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Chongqing Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400014</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>March 18, 2023</study_first_submitted>
  <study_first_submitted_qc>March 30, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">April 3, 2023</study_first_posted>
  <last_update_submitted>March 30, 2023</last_update_submitted>
  <last_update_submitted_qc>March 30, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital of Chongqing Medical University</investigator_affiliation>
    <investigator_full_name>Yuxi Su</investigator_full_name>
    <investigator_title>Children's Hospital of Chongqing Medical University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteosarcoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

